Clik here to view.
United Kingdom: Actavis UK Limited and Others v. Eli Lilly and Company, High...
The Court of Appeal denied Actavis’ claim for declarations of non-infringement in respect of several national designations of Eli Lilly’s European Patent. Whilst agreeing with the High Court that the...
View ArticleClik here to view.
United Kingdom: Actavis UK Limited and others v. Eli Lilly and Company, High...
The High Court has granted the Claimants’ request for declarations of non-infringement (“DNIs”) regarding several national designations of the Defendant’s European Patent for a pemetrexed disodium and...
View ArticleClik here to view.
Plausibility post G2/21 – Apixaban in the UK
On 4 May 2023, a mere two weeks after the conclusion of the hearing, the Court of Appeal handed down its decision in Sandoz and Teva v BMS. The appeal decision is centred on the question of...
View ArticleClik here to view.
It’s not over until the Confidential Annex sings
Introduction On 17 July 2023, the English Court of Appeal handed down its decision in a dispute between J.C. Bamford (JCB) and Manitou about the confidentiality of information disclosed in the course...
View ArticleClik here to view.
Abbott Diabetes Care Inc. v Sibio Technology Limited
Introduction On 19 June 2024, The Hague Local Division handed down a judgment in a dispute brought by Abbott Diabetes Care Inc. (“Abbott”) against Sibio Technology Limited and Umedwings Netherlands BV...
View ArticleClik here to view.
Abbott Diabetes Care Inc. v Sibio Technology Limited – an update
Background In June 2024, we reported that in an application for provisional measures brought by Abbott Diabetes Care against Sibio Technology, The Hague Local Division (“LD”) determined, inter alia,...
View Article